3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
38
Neoplasm Metastasis
16
Leukemia, Myeloid, Acute
13
Skin Neoplasms
10
Kidney Neoplasms
10
Leukemia
9
Carcinoma, Renal Cell
9
Neoplasms
7
Ovarian Neoplasms
6
Breast Neoplasms
6
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Congenital Abnormalities
4
Neuroblastoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Recurrence
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Lymphoma, Mantle-Cell
2
Hodgkin Disease
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Interventions
Temozolomide
53
Bevacizumab
45
Radiotherapy
28
Radiosurgery
21
Carboplatin
14
Erlotinib Hydrochloride
11
Radiation
10
pembrolizumab
9
Magnetic Resonance Spectroscopy
9
Etoposide
9
Vorinostat
8
Trastuzumab
8
Irinotecan
8
Sunitinib
7
Sorafenib
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Lapatinib
7
Capecitabine
7
dabrafenib
6
Ipilimumab
6
Imatinib Mesylate
6
Cyclophosphamide
6
Sirolimus
5
Hydroxyurea
5
Everolimus
5
Bortezomib
5
temsirolimus
4
cabozantinib
4
binimetinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Brain Neoplasms
×
Interleukin-2
×
Clear all
No trials found.